药品说明书翻译讲解学习.ppt

《药品说明书翻译讲解学习.ppt》由会员分享，可在线阅读，更多相关《药品说明书翻译讲解学习.ppt（78页珍藏版）》请在淘文阁 - 分享文档赚钱的网站上搜索。

1、药品说明书翻译n n包括下列内容包括下列内容:n n药品名称药品名称(Drugname)(Drugname)n n性状性状(Description)(Description)n n药理作用药理作用(PharmacologicalActions)(PharmacologicalActions)n n适应症适应症(Indication)(Indication)n n禁忌症禁忌症(Contraindication)(Contraindication)n n注意事项注意事项(Precaution)(Precaution)n n副作用副作用(Sideeffects)(Sideeffects)n n剂量和

2、用法剂量和用法(Dosageandadministration)(Dosageandadministration)n n包装包装(Packing)(Packing)n n有效期有效期(Expirydate)(Expirydate)n n出厂日期出厂日期(Manufacturingdate)(Manufacturingdate)n n参考文献参考文献(References)(References)药品名称有商品名药品名称有商品名(Tradename)(Tradename)、通用名（通用名（GenericNameGenericName）化学名（化学名（ChemicalNameChemicalNam

3、e）药品说明书上最常用的名称是商品名。药品说明书上最常用的名称是商品名。有时在商品名之下（或后）又列有通用名或化学名有时在商品名之下（或后）又列有通用名或化学名.例如：例如：RulideRulide（罗力得）之后（罗力得）之后 列有（列有（RoxithromycinRoxithromycin，罗红，罗红霉素）；霉素）；MinipressMinipress（脉宁平）之后列有（脉宁平）之后列有（PraxosinHClPraxosinHCl，盐酸，盐酸哌唑嗪）哌唑嗪）一药品名称一药品名称(Drug Name)1.1.商品名商品名商品名商品名(Tradename)(Tradename)n n n n商

4、品名是由生产厂家命名并向该国政府有关部门商品名是由生产厂家命名并向该国政府有关部门(国家食品药品管理局国家食品药品管理局)注册的药品名注册的药品名.商品名右商品名右上角往往有一符号上角往往有一符号,意思是注册商标，是意思是注册商标，是RegisterRegister的缩写。的缩写。n n商品名因厂而异商品名因厂而异,因国而异因国而异,一种药物可以有几一种药物可以有几个个,几十个商品名几十个商品名,因此仅根据商品名很难确定该因此仅根据商品名很难确定该药为何种药物药为何种药物,需要查阅其化学结构需要查阅其化学结构.n n药物说明书一开头药物说明书一开头,除了商品名外除了商品名外,还有时标有还有时标

5、有 “Issued to/for the medical profession“Issued to/for the medical profession only”only”意思为意思为“仅供医学界专业参考仅供医学界专业参考”2.2.商品名译法商品名译法商品名译法商品名译法 n n药品名称的中文翻译方法有多种，包括音译、意译、药品名称的中文翻译方法有多种，包括音译、意译、音意合译、谐音译以及按药理作用或药物成分翻译。音意合译、谐音译以及按药理作用或药物成分翻译。n na.a.音译音译音译音译 PenicilinPenicilin盘尼西林，盘尼西林，Cediland(Cediland(西地兰西地

6、兰),),Persantin(Persantin(潘生丁潘生丁),aspirin(),aspirin(阿司匹林阿司匹林)n nb.b.意译意译意译意译 ChlorimycinChlorimycin氯霉素；氯霉素；TetracyclinTetracyclin四环素；四环素；CholicAcidCholicAcid胆酸胆酸n nc.c.音意合译音意合译音意合译音意合译 MedemycinMedemycin麦迪霉素（麦迪霉素（麦迪霉素（麦迪霉素（mycinmycin 霉素）霉素）霉素）霉素）n nd.d.谐音谐音谐音谐音LegalonLegalon利肝隆，利肝隆，WebilinWebilin胃必灵胃

7、必灵 n ne.e.按药理作用或药物成分翻译按药理作用或药物成分翻译按药理作用或药物成分翻译按药理作用或药物成分翻译 二药品性状（二药品性状（Description）药品性状：包括药品的外观、理化性质、成分、结药品性状：包括药品的外观、理化性质、成分、结构、特征等。构、特征等。除了用除了用DescriptionDescription外，还常用外，还常用Property/Properties;Property/Properties;Physicalandchemicalproperties;Physicalandchemicalproperties;Characteristics(Charact

8、eristics(性状性状)；有些说明书介绍很简单，仅给出化学结构或成分，有些说明书介绍很简单，仅给出化学结构或成分，标题为：标题为：n nChemicalstructure(Chemicalstructure(化学结构化学结构););n nComposition(Composition(成分成分)n nActiveingredients(Activeingredients(有效成分有效成分)等等 此部分结构差异较大，长短不一。此部分结构差异较大，长短不一。此部分结构差异较大，长短不一。此部分结构差异较大，长短不一。介绍药物多用介绍药物多用介绍药物多用介绍药物多用被动语态被动语态被动语态被动语

9、态。除了普通性和描述性词汇外，还常涉及到化学除了普通性和描述性词汇外，还常涉及到化学除了普通性和描述性词汇外，还常涉及到化学除了普通性和描述性词汇外，还常涉及到化学化工词汇。化工词汇。化工词汇。化工词汇。由于是对药物性质的一般描述，故由于是对药物性质的一般描述，故由于是对药物性质的一般描述，故由于是对药物性质的一般描述，故多用一般式多用一般式多用一般式多用一般式。1结构特点结构特点：Example 1DescriptionDescriptionn nBuflomedil Buflomedil Hydrochloride,Hydrochloride,the the active active i

10、ngredient ingredient of of Ikelan,Ikelan,is is a a vasoactive vasoactive and and nerve nerve protective protective drug.drug.The The empirical empirical formular formular is is C C1717HH2525NONO4 4.HCl,HCl,representing representing a a molecular molecular weight weight of of 343.8.343.8.Each Each am

11、poule ampoule of of Ikelan Ikelan injection injection contains contains 50mg 50mg Buflomedil Buflomedil Hydrochloride.Hydrochloride.It It is is a a clear,clear,colorless colorless or or light light yellow yellow solution.solution.Each Each film film coated coated tablet tablet for for oral oral admi

12、nistration administration contains contains 150mg 150mg or or 300mg 300mg of of Buflomedil Buflomedil Hydrochloride.Hydrochloride.Each Each ml ml of of the the oral oral solution solution drops drops contains contains 150mg 150mg Buflomedil Buflomedil Hydrochloride.Hydrochloride.Example 2Example 2Pr

13、opertiesPropertiesThisdrugisanangiotensinconvertingenzymeThisdrugisanangiotensinconvertingenzymeinhibitorinhibitor（ACEIACEI）.n nExample 3Example 3n nDescriptionDescriptionn nKirinSterilePowdercontainsspectinomycinKirinSterilePowdercontainsspectinomycinhydrochloridewhichisanaminocyclitolantibioticshy

14、drochloridewhichisanaminocyclitolantibioticsproducedbyaspeciesofsoilmicroorganismdesignatedproducedbyaspeciesofsoilmicroorganismdesignatedasStreptomycesspectabilisasStreptomycesspectabilis.n nExample4Example4n nDescriptionDescription n nFluconazole is a bis-trizole:2-(2,4-difluorophenyl)-Fluconazole

15、 is a bis-trizole:2-(2,4-difluorophenyl)-1,3-bis(11,3-bis(1HH-1,2,4-triazole-1-yl)-2-propanol.It has the-1,2,4-triazole-1-yl)-2-propanol.It has the following structural formula:(omitted)following structural formula:(omitted)n nFluconazole is a white to off-white crystalline powder Fluconazole is a w

16、hite to off-white crystalline powder which is sparingly soluble in water and saline.It has a which is sparingly soluble in water and saline.It has a molecular weight of 306.3.Fluconazole is available as molecular weight of 306.3.Fluconazole is available as gelatin capsule containing 50mg,an intraven

17、ous gelatin capsule containing 50mg,an intravenous infusion containing Fluconazole 2mg/ml in a saline infusion containing Fluconazole 2mg/ml in a saline solutionsolution.n n 例例1 1FolicacidisayellowishtoorangeFolicacidisayellowishtoorange，crystallinecrystallinepowder;odourlessoralmostodourless.powder

18、;odourlessoralmostodourless.n n叶酸是淡黄色至橙色结晶粉沫，无臭或几乎无臭。叶酸是淡黄色至橙色结晶粉沫，无臭或几乎无臭。n n例例2 2Intralipos10%isawhiteopaquefatemulsionforIntralipos10%isawhiteopaquefatemulsionforintravenousinjectionintravenousinjection，containing10W/V%ofpurifiedcontaining10W/V%ofpurifiedsoybeanoil.soybeanoil.n n脂肪乳剂（脂肪乳剂（10%10%）

19、是白色，不透明，供静脉注射用）是白色，不透明，供静脉注射用的脂肪乳剂，含有的脂肪乳剂，含有10%10%（W/VW/V）的精制大豆油。）的精制大豆油。n n 例例3 3UrsosanTablet50mgisawhiteplaintabletwhichUrsosanTablet50mgisawhiteplaintabletwhichcontains50mgofursodeoxycholicacid.contains50mgofursodeoxycholicacid.n n熊去氧胆酸片为白色素片，每片含熊去氧胆酸片为白色素片，每片含50mg50mg熊去氧胆酸。熊去氧胆酸。n n例例4 4Steril

20、epyrogen-freeSterilepyrogen-free，orangeredorangered，freeze-driedfreeze-driedpowderinvialscontaining10mgand50mgofpowderinvialscontaining10mgand50mgofdoxorubicinhydrochloridewithlactose.doxorubicinhydrochloridewithlactose.n n（本品）为小瓶装，灭菌无热原，桔红色冻干粉沫，（本品）为小瓶装，灭菌无热原，桔红色冻干粉沫，每小瓶含有每小瓶含有10mg10mg盐酸阿霉素和盐酸阿霉素和5

21、0mg50mg的乳糖。的乳糖。n n例例5 5Itoccursasawhitetooff-whiteItoccursasawhitetooff-white，crystallinesolidcrystallinesolid，poorlysolubleinwaterpoorlysolubleinwater，diluteacidandmostdiluteacidandmostorganicsolvents.organicsolvents.n n本品（炎痛息康）为白色至类白色结晶固体，难溶本品（炎痛息康）为白色至类白色结晶固体，难溶于水、稀酸及大多数有机溶剂中。于水、稀酸及大多数有机溶剂中。n n例例

22、6 6PaminePamine，chemicallyknownasepoxytropinechemicallyknownasepoxytropinetropatemethylbromidetropatemethylbromide，hastheempiricalformulahastheempiricalformulaC C1818H H2424NONO4 4Brandthemolecularweight398.3.Brandthemolecularweight398.3.哌明的化学名称为环氧莨菪碱托品酸酯溴代甲烷，哌明的化学名称为环氧莨菪碱托品酸酯溴代甲烷，实验式为实验式为C18H24NO4B

23、rC18H24NO4Br，分子量为，分子量为398.3398.3。n n例例7 7KanendomycinisaverystableantibioticKanendomycinisaverystableantibiotic，anditsanditsactivitydoesnotdecreasewhenthepowderisplacedinactivitydoesnotdecreasewhenthepowderisplacedinanairtightcontainerandkeptatroomtemperaturesforanairtightcontainerandkeptatroomtempe

24、raturesformorethan2years.morethan2years.卡内多霉素是一种很稳定的抗生素，其粉沫置于密卡内多霉素是一种很稳定的抗生素，其粉沫置于密封容器中，在室温下保存二年以上，活性不减。封容器中，在室温下保存二年以上，活性不减。n n例例8 8ThisproductispreparedfromunitsofThisproductispreparedfromunitsofhumanplasmawhichhavebeentestedandhumanplasmawhichhavebeentestedandfoundnonreactiveforhepatitisassociat

25、edfoundnonreactiveforhepatitisassociated(Australia)antigen.(Australia)antigen.n n本品由人血浆制备，此血浆业经检验，本品由人血浆制备，此血浆业经检验，并且证明对肝炎（澳大利亚）抗原无反应。并且证明对肝炎（澳大利亚）抗原无反应。2.常用词语n n(1)性状部分常用词语表达性状部分常用词语表达n ncolorcolor颜色颜色tastetaste味道味道n ntastelesstasteless无味无味colorlesscolorless无色无色 n ncrystallinecrystalline结晶的结晶的solub

26、ilitysolubility溶解度溶解度n nyellowishyellowish淡黄色淡黄色bitterbitter苦味苦味n nwhitishwhitish微白色的微白色的odourodour气味气味n ngreenishgreenish淡绿色的淡绿色的odourlessodourless无嗅无嗅 n nsterilesterile灭菌，无菌的灭菌，无菌的n norangeredorangered桔红色的桔红色的n npyrogen-freepyrogen-free无热原的无热原的n nsolublesoluble可容的可容的insolubleinsolublen nbrownbrown

27、棕色棕色n nbrownishbrownish浅棕色的浅棕色的n ntransparenttransparent透明的透明的 n nopaqueopaque不透明的不透明的n noff-whiteoff-white类白色类白色 或或 黄白色的黄白色的n nstablestable稳定的稳定的n nmolecularformularinjectionliquidmolecularformularinjectionliquidn nmolecularweightsolutionpowdermolecularweightsolutionpowdern nchemicalstructuretablet

28、solidchemicalstructuretabletsolid(2)(2)表示组成、来源、制备方法的常用表达表示组成、来源、制备方法的常用表达表示组成、来源、制备方法的常用表达表示组成、来源、制备方法的常用表达n nconstituentsconstituents组成组成;n nprepareprepare制备制备,n nbederivedfrombederivedfrom由由衍生衍生;n nbeobtainedfrombeobtainedfrom由由制的制的;n nbepreparedfrombepreparedfrom由由制备制备;n nobtainedbyobtainedby由由获得

29、获得;n nconsistofconsistof由由组成组成;n nbecomposedofbecomposedof由由组成组成;n ncontain;have;possesscontain;have;possess有（具有）有（具有）三三.药理作用药理作用(Pharmacological Actions)n n较详细的药品说明书一般要介绍药品的临床药理、体较详细的药品说明书一般要介绍药品的临床药理、体外实验、药效、药物代谢、毒性和毒理作用等。该部外实验、药效、药物代谢、毒性和毒理作用等。该部分常用的标题为：分常用的标题为：n nPharmacologicalActionsPharmacolo

30、gicalActions药理作用药理作用n nPharmacologyPharmacology药理学药理学n nPharmacologicalPropertiesPharmacologicalProperties药理性质药理性质n nActionsandpropertiesActionsandproperties作用与性质作用与性质n nMechanismofActionMechanismofAction作用机理作用机理n nModeofActionModeofAction作用方式作用方式n nClinicalExperimentsClinicalExperiments临床实验临床实验n nP

31、harmacologyandtoxicologyPharmacologyandtoxicology药理学与毒理学药理学与毒理学n nBiologicalActivityBiologicalActivity生物活性（若为抗生素类药品，常生物活性（若为抗生素类药品，常用之）用之）n n有时还列出小标题，例如：n nClinicalPharmacologyn n临床药理学;n nClinicaleffect/usen n临床效果/用途;n nPharmacodynamics药效学;n nPharmacokineticsn n药物代谢动力学。n n1 1结构特点结构特点结构特点结构特点 n n该部分涉

32、及到多学科的词汇，如该部分涉及到多学科的词汇，如 药理学（药效学，药理学（药效学，药物代谢动力学）、生理学、毒理学、化学与微生物药物代谢动力学）、生理学、毒理学、化学与微生物学等专业的词汇，有时较难理解。学等专业的词汇，有时较难理解。n n此外，在本部分还经常遇到一些医学缩略词，如：此外，在本部分还经常遇到一些医学缩略词，如：CNSCNS（中枢神经系统）、（中枢神经系统）、EEGEEG（脑电图）、（脑电图）、LDLD5050（半数（半数致死量）、致死量）、EDED5050（半数有效量）、（半数有效量）、t t1/21/2(半衰期半衰期)等。等。该项该项一般用陈述句一般用陈述句，句子结构有时比较

33、复杂。，句子结构有时比较复杂。n nExample 1.Example 1.n nPharmacodynamic and Pharmacokinetic PropertiesPharmacodynamic and Pharmacokinetic Propertiesn nBuflomedilisaweak,non-specific,calciumantagonistand-Buflomedilisaweak,non-specific,calciumantagonistand-adrenergicreceptorinhibitor.Itimprovesmicrocirculationbyadre

34、nergicreceptorinhibitor.Itimprovesmicrocirculationbyincreasingerythrocyteflexibility,inhibitingplateletaggregation,increasingerythrocyteflexibility,inhibitingplateletaggregation,decreasingvascularresistance.Thedrugalsoimprovestissuedecreasingvascularresistance.Thedrugalsoimprovestissueoxygenationand

35、increasesATPproduction.oxygenationandincreasesATPproduction.n nTheabsolutebioavailabilityofthedrugrangesfrom50%to80%Theabsolutebioavailabilityofthedrugrangesfrom50%to80%aftertheadministrationofasingleoraldose.Thedegreeofproteinaftertheadministrationofasingleoraldose.ThedegreeofproteinbindingofBuflom

36、edilchangesaccordingtotheserumconcentration.bindingofBuflomedilchangesaccordingtotheserumconcentration.Proteinbindingis81%at0.5mg/L,6l%at5mg/Land25%at50Proteinbindingis81%at0.5mg/L,6l%at5mg/Land25%at50mg/L.Themeaneliminationhalf-lifeis2to4hours.12%to28%ofmg/L.Themeaneliminationhalf-lifeis2to4hours.1

37、2%to28%ofasingleora1ori.v.doseiseliminatedunchangedintheurineoverasingleora1ori.v.doseiseliminatedunchangedintheurineover48hours,andanequalpercentageasthepara-demethylmetabolite.48hours,andanequalpercentageasthepara-demethylmetabolite.n nExample2Example2n nClinicalPharmacologyClinicalPharmacologyn n

38、SpectinomycinhydrochlorideisaninhibitorofSpectinomycinhydrochlorideisaninhibitorofproteinsynthesisinthebacterialcell;thesiteofproteinsynthesisinthebacterialcell;thesiteofactionisthe30Sribosomalsubunit.actionisthe30Sribosomalsubunit.n nInvitrostudieshaveshownspectinomycinInvitrostudieshaveshownspecti

39、nomycinhydrochloridetobeactiveagainstmoststrainsofhydrochloridetobeactiveagainstmoststrainsofNeisseriagonorrhoea(minimuminhibitoryNeisseriagonorrhoea(minimuminhibitoryconcentrationconcentration7.5to20mcg/ml).Definitivein7.5to20mcg/ml).Definitiveinvitrostudieshaveshownnocross-resistanceofN.vitrostudi

40、eshaveshownnocross-resistanceofN.gonorrheabetweenspectinomycinhydrochloridegonorrheabetweenspectinomycinhydrochlorideandpenicillin.Theantibioticisnotsignificantlyandpenicillin.Theantibioticisnotsignificantlyboundtoplasmaprotein.boundtoplasmaprotein.n nExample 3Example 3n nHuman PharmacologyHuman Pha

41、rmacologyn nKirinSterilePowder(spectinomycinhydrochloride)KirinSterilePowder(spectinomycinhydrochloride)israpidlyabsorbedafterintramuscu1arinjection.Aisrapidlyabsorbedafterintramuscu1arinjection.Asingle,twograminjectionproducespeakserumsingle,twograminjectionproducespeakserumconcentrations(averaging

42、about100mg/mlatoneconcentrations(averagingabout100mg/mlatonehour.Averageserumconcentrationsof15mg/mlhour.Averageserumconcentrationsof15mg/mlforthetwogramdosewaspresenteighthoursforthetwogramdosewaspresenteighthoursafterdosing.)afterdosing.)n nExample 4Example 4n nBasedoninspectionofeachpatientsBased

43、oninspectionofeachpatientspharmacokineticcurves,thedistributionpharmacokineticcurves,thedistributionphaseofWR2721sremovalfromplasmaphaseofWR2721sremovalfromplasmapredominatesandiscompletewithin6minpredominatesandiscompletewithin6minafterdrugadministration.afterdrugadministration.2常用词语常用词语（1 1）动词）动词）

44、动词）动词：n nIndicateIndicate表明，提示；表明，提示；n nMaintainMaintain维持；维持；n nDemonstrateDemonstrate显示；显示；n nexert(actionon)exert(actionon)起一作用起一作用n nExhibitExhibit显示；显示；n nInhibit抑制；n nAccumulate积蓄（积累）；n nmetabolize代谢；n nAdminister给药；n nExcrete排泄；n nTolerate耐受（2）形容词）形容词：n naveragemean平均的；n nbeeffectiveagainst对有

45、效；n nberelatedto与有关；n n（be）sensitiveto对敏感；n n（be）resistantto对有耐药（3）名）名 词词 n nActivity活性；n nMechanism机理；n nAbsorption吸收；n nDistribution分布；n nElimination清除；n nExcretion排泄，n nSerumconcentration血清浓度；n nTolerance耐受性;n nClearancerate廓清率；n nToxicity毒性；n nPlasmalevel血浆浓度（水平）；n nHalflife半衰期；n nEffecton对的作用;n

46、 nInvitro体外；n ninvivo体内。四适应症四适应症 Indicationsn n该项是药品说明书的重点，常用标题：n nIndications 适应症;n nIndications and Usage 适应症与用途；n nMajor Principal Indications 主要适应症；n nUses 用途；n nAction and Use 作用与用途。n n1结构特点结构特点n n一般说，该项仅列出疾病名称，或用短语表一般说，该项仅列出疾病名称，或用短语表示该药能治疗的疾病。示该药能治疗的疾病。n n较详细的说明书亦用完整的句子表述该药能较详细的说明书亦用完整的句子表述该药

47、能治疗什么病，及对哪些细菌和微生物有效或治疗什么病，及对哪些细菌和微生物有效或无效。由于疾病和细菌、病毒名称太多，请无效。由于疾病和细菌、病毒名称太多，请查阅英汉医学词汇等工具书。查阅英汉医学词汇等工具书。n nExample 1Example 1n nIndicationsIndicationsn nPreventionandlong-termtreatmentofanginaPreventionandlong-termtreatmentofanginapectoris.pectoris.n nTreatmentofsevereheartfailureincombinationTreatme

48、ntofsevereheartfailureincombinationwithcardiacglycosides,preparationspromotingwithcardiacglycosides,preparationspromotingsecretionofurine,ACEinhibitors,drugscausingsecretionofurine,ACEinhibitors,drugscausingadilationofthearterialbloodvessels.adilationofthearterialbloodvessels.n nHighpressureinthepu1

49、monarycirculation.Highpressureinthepu1monarycirculation.n nExample 2Example 2n nIndicationsIndicationsn nTimentinisindicatedforawiderangeofinfectionsTimentinisindicatedforawiderangeofinfectionsforwhichsusceptibleorganismshavebeenforwhichsusceptibleorganismshavebeendetectedoraresuspected.Typicalindic

50、ationsdetectedoraresuspected.Typicalindicationsinclude:include:n nSevereinfections,forexample:Severeinfections,forexample:n nSepticaemiaSepticaemia，BacteraemiaBacteraemia，PeritonitisPeritonitis，intra-intra-abdominalsepsisabdominalsepsis，Post-surgicalinfections,Post-surgicalinfections,n nBoneandjoint